News in the Life Sciences Industry

LONDON, March 25, 2019 /PRNewswire/ -- Global health service company Cigna Corporation (NYSE:CI) today released the results of its global 2019 Cigna 360 Well-Being Survey - "Well and Beyond". The Cigna 360 Well-Being Survey, now in its... Read more ››

MARLBOROUGH, Mass., March 25, 2019 /PRNewswire/ -- CardioFocus, Inc., a medical device company dedicated to advancing ablation... Read more ››

BOSTON, March 25, 2019 /PRNewswire/ -- Bioelectronic medicine, referring to technologies that utilize electrical stimulation to treat conditions of the human body, has been in use for many decades for the treatment of cardiac conditions. As companies continue to develop and commercialize new... Read more ››

- Real-world evidence reinforces TAILORx treatment paradigm and standard of care use for Oncotype DX(®) test

POTSDAM, Germany, March 25, 2019 /PRNewswire/ -- At the XIIIth Annual Congress of the European Proteomics Association (www.eupa.org), Bruker... Read more ››

NEW ORLEANS, March 25, 2019 /PRNewswire/ -- Oral semaglutide 7 mg and 14 mg demonstrated superior HbA(1c) and body weight reductions compared to Januvia(®) (sitagliptin 100 mg). Non-inferiority for oral semaglutide 3 mg for HbA(1c) reductions at 26 weeks was not confirmed. Presented today at... Read more ››

SYDNEY, March 25, 2019 /PRNewswire/ -- Australian oncology-focused biotech company Kazia Therapeutics Ltd (ASX: KZA, NASDAQ: KZIA) has been selected to present data from the Phase I study of Cantrixil in ovarian cancer at the American Association for Cancer Research (AACR) 2019 Annual Meeting.

BEIJING, March 24, 2019 /PRNewswire/ -- Sanofi Chief Executive Officer Olivier Brandicourt expressed yesterday that he is very glad to be able to participate in the 2019 edition of the China Development Forum, particularly as it marks the 20(th) anniversary of the Forum.